6533b7ddfe1ef96bd12752f5

RESEARCH PRODUCT

Oral rehabilitation with dental implants in patients with recessive dystrophic epidermolysis bullosa : a retrospective study with 2-15 years of follow-up

David Peñarrocha OltraRubén Agustín PanaderoBlanca Serra PastorMaría Peñarrocha DiagoMiguel Peñarrocha Diago

subject

Adultmedicine.medical_treatmentDentistry03 medical and health sciencesYoung Adult0302 clinical medicinePatient satisfactionmedicineMucositisMaxillaHumansJaw EdentulousDental Restoration FailureDental implantGeneral DentistrySurvival rateRetrospective StudiesDental ImplantsOral Medicine and Pathologybusiness.industryResearchDental prosthesisDental Implantation EndosseousEpidermolysis bullosa dystrophica030206 dentistryMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Epidermolysis Bullosa DystrophicaTreatment OutcomeOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASQuality of LifeSurgeryEpidermolysis bullosaImplantDental Prosthesis Implant-SupportedbusinessFollow-Up Studies

description

Background Epidermolysis bullosa (EB) comprises a group of hereditary disorders characterized by mechanical fragility of the skin and mucous membranes, with the development of blisters and vesicles in response to minimum tissue friction. Recessive dystrophic epidermolysis bullosa (RDEB) with generalized involvement is the most common subtype in the oral cavity. The present study was carried out to investigate dental implant survival, peri-implant tissue condition, patient satisfaction, and the impact of treatment upon the quality of life of patients with RDEB rehabilitated with implants and full-arch implant-supported prostheses. Material and Methods Thirteen patients with RDEB underwent dental implant treatment between September 2005 and December 2016. A retrospective study was made to analyze implant survival, peri-implant tissue health and patient satisfaction. Results A total of 80 implants were placed (42 in the maxilla and 38 in the mandible) in 13 patients between 20-52 years of age and diagnosed with RDEB. All the implants were rehabilitated on a deferred basis with 20 full-arch prostheses. Fifteen fixed prostheses and 5 implant-supported overdentures were placed. The implant survival rate was 97.5% after a mean follow-up of 7.5 years after prosthetic loading. Fifty percent of the implants showed mucositis at the time of evaluation. Probing depth was maintained at 1-3 mm in 96.2% of the implants, and bleeding upon probing was observed in 67.5% of the implants. There was a high prevalence of bacterial plaque (85%). Conclusions The treatment of edentulous patients with RDEB by means of implants and implant-supported prostheses is predictable as evidenced by the high success rate, and improves patient self-esteem and quality of life. Key words:Epidermolysis bullosa, dental implants, implant-supported prostheses.

yearjournalcountryeditionlanguage
2019-07-16
https://hdl.handle.net/10550/77109